Welcome to
Sysmex Flow Cytometry Other European Country!

For ordering please make sure you are in your local shop.
If you are from Other European Country then please continue.
Otherwise please go to your country.

Go to my country Continue

Article successfully added.

CyFlow™ CD19 APC

CyFlow™ CD19 APC
Antigen: CD19
Alternative Name: B4
Clone: 4G7
Application: Flow cytometry
Format/Fluorochrome: APC
Laser: Red
Target Species: Human
Field of Interest: Immunophenotyping
Species of Origin: Mouse
Regulatory Status: RUO
Clonality: monoclonal
Emission Maximum: 660 nm
Excitation Maximum: 650 nm
Isotype: IgG1
Order number: AP873420

For Research Use Only
Not for use in diagnostic or therapeutic procedures.

Quantity 100 tests Volume 1 Immunogen Human Chronic Lymphocytic Leukemia (CLL) cells... more
CyFlow™ CD19 APC
Quantity100 tests
ImmunogenHuman Chronic Lymphocytic Leukemia (CLL) cells
Background InformationCD19 is a transmembrane glycoprotein of Ig superfamily expressed by B cells from the time of heavy chain rearrangement until plasma cell differentiation. It forms a tetrameric complex with CD21 (complement receptor type 2), CD81 (TAPA-1) and Leu13. Together with BCR (B cell antigen receptor), this complex signals to decrease B cell treshold for activation by the antigen. Besides being signal-amplifying coreceptor for BCR, CD19 can also signal independently of BCR coligation and it turns out to be a central regulatory component upon which multiple signaling pathways converge. Mutation of the CD19 gene results in hypogammaglobulinemia, whereas CD19 overexpression causes B cell hyperactivity.
UsageThe reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 10·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.

Specific References

| Reinherz EL, Haynes BF, Nadler LM, Bernstein ID: Leukocyte Typing II, Volume 1 Human T Lymphocytes. Springer·Verlag,·New·York. 1986; 1:1‑549. <·PMID:·Springer·8587-5·> | Muench MO, Roncarolo MG, Namikawa R: Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. Blood. 1997·Feb·15; 89(4):1364‑75. <·PMID:·9028960·> | Stockmeyer B, Dechant M, van Egmond M, Tutt AL, Sundarapandiyan K, Graziano RF, Repp R, Kalden JR, Gramatzki M, Glennie MJ, van de Winkel JG, Valerius T: Triggering Fc alpha‑receptor I (CD8{09} recruits neutrophils as effector cells for CD20‑directed antibody therapy. J·Immunol. 2000·Nov·15; 165(10):5954‑61. <·PMID:·11067958·> | Dubois B, Massacrier C, Caux C: Selective attraction of naive and memory B cells by dendritic cells. J·Leukoc·Biol. 2001·Oct; 70(4):633‑41. <·PMID:·11590201·> | Basu S, Lynne CM, Ruiz P, Aballa TC, Ferrell SM, Brackett NL: Cytofluorographic identification of activated T‑cell subpopulations in the semen of men with spinal cord injuries. J·Androl. 2002·Jul-Aug; 23(4):551‑6. <·PMID:·12065463·> | Porcellini S, Vallanti G, Nozza S, Poli G, Lazzarin A, Tambussi G, Siccardi AG, Grassi F: Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL‑2 administration. AIDS. 2003·Jul·25; 17(11):1621‑30. <·PMID:·12853744·> | Treusch M, Vonthein R, Baur M, Günaydin I, Koch S, Stübiger N, Eckstein AK, Peter HH, Ness T, Zierhut M, Kötter I: Influence of human recombinant interferon‑alpha2a (rhIFN‑alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology·(Oxford). 2004·Oct; 43(10):1275‑82. <·PMID:·15252211·> | Köller M, Zwölfer B, Steiner G, Smolen JS, Scheinecker C: Phenotypic and functional deficiencies of monocyte‑derived dendritic cells in systemic lupus erythematosus (SLE) patients. Int·Immunol. 2004·Nov; 16(11):1595‑604. <·PMID:·15381672·> | Martino V, Tonelli R, Montemurro L, Franzoni M, Marino F, Fazzina R, Pession A: Down‑regulation of MLL‑AF9, MLL and MYC expression is not obligatory for monocyte‑macrophage maturation in AML‑M5 cell lines carrying t(9: 11)(p22: q23). Oncol·Rep. 2006·Jan; 15(1):207‑11. <·PMID:·16328057·> | Andersen P, Pedersen MW, Woetmann A, Villingshøj M, Stockhausen MT, Odum N, Poulsen HS: EGFR induces expression of IRF‑1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells. Int·J·Cancer. 2008·Jan·15; 122(2):342‑9. <·PMID:·17918184·>